TSS:Hg 35251.1

Basic information about the TSS

---

TSS ID: hg_35251.1 Species: human Chr: chr3		Start: 9890664 End: 9890675 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AF212230 Distance: -21 GeneID: 84522 HGNC/MGI_ID: HGNC:26926 UniProt_ID: Q9BY51

Gene_name: jagunal homolog 1 Gene_symbol: JAGN1 Gene_synonyms: FLJ14602 GL009 Gene_source: HGNC:26926

TATA-Box annotation

---

Distance to TSS:	60
Nearest PromoterID:	NM_032492
Entrez ID:	84522
Nearest Unigene:	Hs.24054
Nearest Refseq:	NM_032492
Nearest Ensembl:	ENSG00000171135
Gene Name:	jagunal homolog 1
Gene Alias:	GL009|SCN6
Gene Description:	jagunal homolog 1
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.696517
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@JAGN1 p2@JAGN1 p3@JAGN1 p4@JAGN1 p5@JAGN1
Sample		p1@JAGN1	p2@JAGN1	p3@JAGN1	p4@JAGN1	p5@JAGN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.79	25.13	1.75	5.84	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	31.36	31.56	1.82	3.44	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.81	29.71	1.54	5.79	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.04	32.64	1.25	5.61	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.92	29.25	0.90	8.32	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	21.13	36.24	1.94	4.46	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.46	35.30	2.61	6.54	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	35.85	27.61	1.94	6.30	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	37.83	35.26	3.42	5.77	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.34	32.46	1.16	6.38	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	24.66	25.06	1.21	3.64	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.39	25.61	2.03	4.47	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.67	5.32	0.32	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.30	5.11	0.15	0.15	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.52	4.17	0.44	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.11	5.28	0.25	0.25	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.88	5.90	0.66	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.29	5.91	0.42	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	6.93	0.00	0.53	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	25.12	7.22	0.15	0.90	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	23.52	6.82	0.13	1.47	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.99	9.49	1.55	0.86	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	21.59	6.46	0.52	1.29	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.81	4.61	0.24	1.70	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	24.25	7.48	0.26	0.26	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	23.42	6.01	0.63	1.27	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.08	8.79	1.65	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.65	13.44	1.18	2.36	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	29.72	9.05	1.62	0.81	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.25	7.78	1.09	1.63	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.63	9.42	1.47	1.67	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.66	10.55	1.37	1.17	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.58	11.61	1.90	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.27	12.87	1.48	2.64	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.88	8.79	0.93	2.06	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.76	11.69	1.34	1.92	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.87	11.45	1.23	1.64	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.15	8.26	1.01	2.22	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	18.64	9.99	1.08	1.89	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.85	11.76	0.24	1.44	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.06	9.41	1.18	2.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.64	10.39	1.17	1.46	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.97	10.54	1.27	1.90	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.78	11.71	1.05	0.87	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.86	9.24	1.81	1.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.80	9.54	0.23	1.86	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.03	7.20	1.68	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.57	9.54	1.49	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.88	7.18	1.91	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	15.16	8.49	1.21	1.01	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.04	9.02	0.82	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.01	10.23	1.33	0.89	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	41.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.90	8.87	1.77	1.77	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.57	8.62	0.33	0.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	18.46	3.36	0.84	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.98	8.73	0.46	1.38	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.80	6.48	2.27	0.65	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.59	7.39	0.00	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	27.03	6.92	0.63	0.63	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	2.82	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	6.73	2.24	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.88	3.18	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.78	5.78	1.02	1.36	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.70	2.60	1.30	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	16.68	5.32	0.71	0.35	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	7.90	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	9.75	0.00	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.83	3.97	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.89	10.79	0.47	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.19	8.61	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.47	5.26	0.62	0.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.15	6.42	0.00	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	20.11	14.25	1.90	2.06	0.95
Adipocyte - breast, donor2	11327-117E4	21.02	12.35	1.60	1.28	1.28
Adipocyte - omental, donor1	11473-119C6	23.03	11.96	3.56	2.54	1.65
Adipocyte - omental, donor2	11474-119C7	25.41	8.97	1.49	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	26.46	7.70	2.01	2.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	24.88	5.74	2.55	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	14.29	2.20	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	27.10	15.36	1.35	4.52	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	49.53	21.03	3.65	4.69	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	25.82	9.00	1.56	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	19.56	7.46	1.03	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	17.56	6.41	1.12	0.84	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	18.81	5.88	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	25.34	11.34	1.61	1.45	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	16.46	7.42	0.65	4.20	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	11.73	5.33	1.07	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	9.46	2.23	2.23	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	30.78	8.73	2.50	2.91	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	22.35	8.04	0.75	2.01	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	19.31	8.51	1.96	3.27	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	15.53	6.09	1.83	1.52	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	32.04	10.17	0.66	1.33	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	35.50	7.53	1.43	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	26.36	3.59	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	50.19	9.36	2.34	0.72	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	41.84	6.69	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	35.95	9.04	2.26	1.03	0.00
Anulus Pulposus Cell, donor1	11248-116E6	56.76	16.59	1.72	0.92	0.34
Anulus Pulposus Cell, donor2	11463-119B5	56.33	10.78	1.71	1.71	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.48	3.15	1.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.61	3.91	2.17	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	6.42	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.51	3.29	1.20	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	29.09	3.79	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	3.30	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	20.79	2.60	0.65	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.48	1.94	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	3.56	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	21.09	3.01	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	4.35	5.81	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	7.52	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	26.36	4.61	0.99	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	4.09	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.37	5.43	1.36	1.51	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.00	4.82	2.14	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	18.33	4.72	1.51	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.18	6.15	1.07	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	24.39	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.74	2.49	1.16	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	7.20	0.00	0.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	3.54	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.73	3.09	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	23.79	4.37	3.40	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	25.80	4.55	1.14	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	4.85	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	6.84	2.85	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	21.81	2.14	1.28	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.52	2.84	1.55	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	23.93	4.69	2.82	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	25.40	5.79	1.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	16.41	2.85	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	1.75	1.75	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	22.58	4.52	0.90	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	5.94	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.41	4.58	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	16.55	4.08	1.78	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	3.18	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.58	4.32	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	22.86	3.18	0.64	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.98	3.19	1.45	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.95	3.78	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.00	4.58	0.68	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	6.95	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	8.45	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	17.37	3.86	1.29	0.64	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.04	6.62	2.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	23.33	3.64	2.19	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	20.00	5.75	2.07	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	12.75	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	25.17	6.10	3.81	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.39	5.57	0.62	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.91	4.28	1.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.60	4.30	3.35	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	22.40	5.54	0.89	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	7.63	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.82	3.88	1.66	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.39	4.24	1.32	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.08	4.72	2.54	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	31.69	6.63	0.61	0.98	0.00
Astrocyte - cerebellum, donor2	11580-120F5	29.78	3.94	1.03	0.86	0.51
Astrocyte - cerebellum, donor3	11661-122F5	22.65	10.07	0.63	1.05	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	20.92	8.37	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	19.25	9.06	1.13	0.81	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	21.48	9.10	1.19	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	19.15	4.93	0.80	0.46	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	18.04	5.01	1.13	0.63	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.79	4.89	1.02	0.34	0.23
Basophils, donor1	12241-129G9	19.09	0.78	1.31	0.00	0.26
Basophils, donor2	12242-129H1	16.24	0.72	0.36	0.36	0.00
Basophils, donor3	12243-129H2	17.05	0.88	1.18	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	27.38	5.17	1.94	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	18.29	5.03	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.83	5.65	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	26.20	6.03	0.83	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	20.50	5.53	0.23	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	20.87	4.50	0.54	0.54	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	34.94	7.32	1.34	1.96	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	45.18	5.82	1.40	1.63	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	56.60	6.08	3.20	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	17.47	1.13	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	12.44	0.93	1.11	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	13.17	1.98	1.32	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	26.61	1.13	1.70	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.05	3.41	1.52	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	29.92	2.63	1.64	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	13.73	1.01	0.72	0.87	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	9.35	1.21	0.91	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	12.56	2.61	0.24	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.70	0.84	0.84	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.18	2.21	0.00	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.43	1.49	0.99	0.99	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.07	1.37	0.98	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	6.05	0.71	0.36	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.79	2.18	1.09	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.19	0.94	0.70	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	9.50	1.58	1.06	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	8.87	1.11	1.11	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.94	0.89	0.74	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.18	2.00	0.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	14.78	3.33	0.62	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.72	0.92	1.14	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.79	0.68	0.45	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	4.80	1.75	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.72	0.27	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.98	2.09	0.17	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	13.89	1.26	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.88	1.10	0.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.87	2.11	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.14	2.19	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.58	0.70	0.35	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.20	1.86	0.00	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.29	2.59	1.51	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.09	1.64	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.56	2.78	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.26	2.32	0.93	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	18.09	1.96	0.87	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	22.64	1.15	1.15	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	24.69	2.60	1.08	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	21.80	1.71	1.25	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	28.64	1.22	1.75	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	18.51	0.22	2.90	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	29.60	2.81	2.30	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	23.27	2.63	1.54	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	22.32	2.32	2.11	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	67.07	12.19	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	65.76	5.42	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	64.21	12.43	3.11	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	47.97	8.53	2.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	76.66	11.26	1.07	1.07	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	54.75	7.02	2.11	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	58.83	10.98	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	64.60	14.50	0.00	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	23.84	5.75	2.47	3.29	1.64
CD19+ B Cells, donor2	11624-122B4	27.57	3.63	1.45	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	22.21	3.03	2.02	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	25.05	5.25	3.23	1.21	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.97	4.79	2.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	27.11	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	47.75	0.56	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.98	2.63	2.63	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	66.07	5.19	1.35	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	36.06	2.14	1.79	1.43	0.00
CD4+ T Cells, donor2	11306-117C1	28.78	2.45	4.29	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	25.92	3.05	3.05	1.83	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	37.01	2.04	1.79	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	37.73	3.37	1.35	0.22	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	37.94	4.89	3.16	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	58.79	6.16	3.32	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	77.26	4.21	4.92	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	59.33	6.59	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	30.64	1.01	1.88	0.29	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	28.81	4.58	1.69	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.83	1.45	1.77	0.48	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	39.00	3.14	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	39.83	3.49	2.10	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.04	3.08	1.32	0.44	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	33.31	2.95	1.69	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	28.67	3.95	1.66	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	25.73	3.68	0.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	38.34	3.81	1.63	0.82	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	46.09	3.22	2.14	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	0.00	7.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.56	2.23	3.52	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	31.63	3.47	2.17	0.22	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	40.35	2.73	2.10	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	35.39	4.55	1.01	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	43.33	3.03	1.73	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	33.12	3.49	1.31	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	59.88	5.44	1.98	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	69.24	5.54	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	79.56	2.79	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	75.88	2.22	3.05	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	72.88	3.68	3.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	66.22	4.62	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	61.24	3.94	1.43	0.72	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	73.40	5.54	2.77	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	23.57	4.58	2.29	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	18.77	4.51	2.63	1.88	0.38
CD8+ T Cells, donor3	11383-118B6	31.06	4.29	0.76	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	26.15	16.06	1.84	3.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.97	14.62	0.96	4.79	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.50	13.68	1.09	2.19	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	22.52	19.51	3.30	5.70	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.24	19.44	1.68	3.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.01	14.33	0.45	3.64	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.64	16.30	0.87	3.26	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	20.00	14.48	1.32	2.90	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.17	15.24	0.23	4.22	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.83	17.81	3.92	3.02	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.88	18.30	2.03	4.65	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	27.18	14.65	0.80	2.93	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	10.94	0.44	2.19	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	18.22	11.84	2.28	4.10	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	2.98	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.53	19.09	2.16	5.04	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	21.00	12.95	2.01	4.60	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.26	16.26	1.65	3.06	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.04	14.26	0.63	3.80	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	29.22	15.99	0.92	3.08	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.03	15.71	1.28	3.53	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	29.45	14.53	0.76	3.44	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.62	13.79	2.36	2.36	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	16.64	0.76	4.54	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	22.48	12.85	0.00	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.18	18.19	1.40	5.60	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	33.06	12.02	4.01	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	20.11	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	32.61	11.86	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	28.52	8.00	1.05	0.42	0.11
Chondrocyte - de diff, donor1	11261-116G1	19.76	2.43	1.04	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	28.79	5.33	1.07	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	23.67	6.14	1.02	0.34	0.00
Chondrocyte - re diff, donor2	11339-117F7	15.22	3.58	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	19.01	4.85	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	20.89	14.92	1.15	1.38	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	12.40	11.12	0.64	1.71	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	17.43	11.15	1.15	1.86	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	20.17	6.69	2.57	1.38	0.09
Corneal Epithelial Cells, donor1	11526-119I5	23.93	7.47	2.20	1.76	0.44
Corneal Epithelial Cells, donor2	11606-120I4	21.61	3.41	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	21.98	7.92	2.05	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.74	4.95	1.49	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.25	6.62	1.26	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	14.36	4.43	1.30	0.65	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	20.84	2.05	0.00	1.37	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	29.38	1.31	1.31	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	32.91	1.94	0.97	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	22.18	3.34	1.17	0.83	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	19.36	4.69	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	22.62	5.94	0.28	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.83	4.33	1.18	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	16.00	5.53	0.58	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	23.76	5.65	1.41	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	23.32	5.43	0.88	0.88	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.03	6.43	1.11	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.39	4.56	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	16.63	3.95	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	34.47	5.05	0.89	0.59	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	24.47	5.73	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	21.41	3.83	0.71	0.71	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	31.21	8.40	0.80	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	17.82	5.24	0.52	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.71	8.20	0.62	0.37	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	15.64	5.43	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	19.78	5.01	0.37	0.61	0.00
Endothelial Cells - Vein, donor1	11267-116G7	25.03	9.10	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	29.34	6.99	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	25.12	5.02	0.63	0.00	0.16
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	14.85	3.30	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	7.13	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	23.70	6.35	1.47	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	4.16	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	5.34	0.41	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.81	4.60	0.99	0.99	1.53
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.14	3.68	1.08	0.11	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.40	7.40	1.33	0.49	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.33	3.68	1.09	0.55	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.97	4.32	1.05	0.63	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.65	3.43	2.37	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.28	4.32	1.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	24.04	8.62	1.81	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	18.95	3.79	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.45	8.04	0.32	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	26.67	6.06	0.61	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	29.44	7.36	1.14	1.52	0.51
Fibroblast - Cardiac, donor6	11460-119B2	22.59	7.73	0.91	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.70	7.77	1.21	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.96	6.47	2.16	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	8.79	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	38.29	11.76	2.08	1.38	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	54.61	6.78	1.36	0.68	0.17
Fibroblast - Dermal, donor1	11269-116G9	22.77	10.57	0.94	2.11	1.17
Fibroblast - Dermal, donor2	11346-117G5	29.72	5.19	1.89	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	24.90	17.41	0.60	2.54	0.24
Fibroblast - Dermal, donor4	11450-119A1	26.68	7.46	1.58	0.90	0.00
Fibroblast - Dermal, donor5	11454-119A5	24.95	12.21	1.40	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	32.81	9.75	1.30	1.14	0.16
Fibroblast - Gingival, donor1	11237-116D4	34.98	7.91	2.29	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.41	6.81	0.52	1.31	0.52
Fibroblast - Gingival, donor2	11318-117D4	28.47	7.51	1.05	0.66	0.00
Fibroblast - Gingival, donor3	11394-118C8	34.03	6.57	1.64	0.29	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	6.23	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.33	4.58	0.70	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.29	6.86	1.25	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.17	6.22	0.54	0.54	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.12	5.29	1.41	0.71	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.41	4.53	0.73	0.73	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	14.04	4.64	1.50	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	16.67	3.18	1.10	0.55	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.99	4.70	0.59	0.73	0.15
Fibroblast - Lung, donor1	11270-116H1	40.78	5.44	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	4.48	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	36.09	12.24	1.06	1.06	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	43.32	11.66	0.00	3.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	4.20	4.20	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.31	4.76	0.84	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	41.81	12.99	4.06	3.25	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	38.99	7.37	2.13	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	26.24	6.83	1.52	0.91	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.95	5.51	1.22	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.50	5.34	0.76	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	5.40	1.62	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.28	5.80	1.51	0.46	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.31	11.05	1.44	1.44	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	29.46	16.26	2.03	1.63	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	32.74	6.68	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	41.12	6.72	1.98	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.11	3.77	0.60	0.60	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	26.29	5.68	1.07	0.71	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	20.10	5.32	0.39	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.56	4.21	1.50	1.50	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	18.78	7.34	0.65	0.76	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	13.16	1.01	1.52	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	23.79	4.27	1.97	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.44	5.01	1.60	1.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	18.49	4.42	1.21	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.37	3.32	0.60	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.14	7.21	0.83	1.41	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	35.90	6.67	0.85	0.68	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.75	3.61	0.33	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	20.24	4.58	0.96	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	23.28	8.60	0.67	1.52	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.46	2.67	2.04	0.16	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	6.97	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	19.94	6.93	2.43	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.52	6.51	3.12	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.44	5.11	1.28	2.04	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.20	16.08	1.53	4.59	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	23.61	22.97	2.55	5.10	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	27.10	10.84	1.71	2.57	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.57	17.92	0.28	2.48	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.97	9.82	1.14	1.14	5.94
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.78	13.47	0.99	2.18	2.77
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	37.80	15.07	0.79	1.85	7.67
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	29.68	10.11	1.30	1.63	3.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.19	11.06	0.00	3.10	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	25.30	8.62	1.13	1.55	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.20	7.27	0.74	1.72	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.07	8.60	1.07	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	21.19	11.52	0.50	1.49	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	24.09	12.87	0.97	1.94	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.65	9.35	0.61	1.63	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.64	7.99	0.68	0.91	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	27.53	7.47	0.25	1.87	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	18.14	4.59	0.00	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.50	6.80	0.59	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.96	7.15	1.27	0.95	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.67	6.26	0.67	1.56	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.64	6.45	1.01	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.72	12.38	0.68	1.02	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.42	10.37	1.33	0.80	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	33.61	7.91	0.62	0.83	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.96	6.49	0.00	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	34.30	6.97	1.22	1.00	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.79	8.40	1.16	1.16	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.20	8.78	1.23	0.82	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.25	6.40	0.62	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	36.09	8.07	0.46	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.85	7.84	1.00	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	29.98	7.72	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	39.36	8.98	0.74	0.86	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.07	10.21	0.32	0.97	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.49	5.77	1.28	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	33.07	7.68	1.14	0.57	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.57	6.17	0.95	0.47	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.33	4.56	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.47	7.63	0.94	0.84	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.88	8.78	0.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	29.18	7.57	0.56	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.55	7.50	2.04	0.83	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.33	7.49	1.07	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.17	9.33	1.22	0.46	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	27.98	10.23	1.17	0.78	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.57	5.15	0.54	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	26.18	6.45	1.11	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.63	8.33	0.66	0.22	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	17.85	1.98	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.39	7.52	0.92	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.81	6.86	0.81	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	23.13	7.62	1.52	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	23.29	8.96	1.00	1.59	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	16.95	8.01	0.92	1.54	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	25.98	10.02	1.64	2.45	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.42	22.84	1.88	4.38	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.14	22.89	0.57	1.41	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	28.13	13.84	0.00	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	7.42	0.00	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.92	16.63	0.39	4.25	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	19.25	0.00	3.21	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	12.17	0.00	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	34.50	15.95	0.33	2.93	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.89	14.41	1.24	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	6.66	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	32.72	12.86	1.12	3.64	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.65	13.07	1.31	2.29	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	33.55	11.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	36.26	10.18	1.59	3.18	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	32.61	15.28	0.34	1.36	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	45.94	22.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	46.96	12.03	1.15	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	41.14	12.43	0.89	0.89	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	54.21	15.25	5.08	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	37.28	12.84	2.07	1.66	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	37.51	11.05	1.15	2.07	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	5.27	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	42.67	12.69	1.54	1.92	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	45.31	11.73	1.30	2.28	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	49.49	11.37	2.01	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	60.10	11.56	1.54	1.16	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	40.40	21.23	0.68	4.11	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.04	7.55	1.42	0.47	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	56.73	12.07	1.81	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	60.02	9.66	1.53	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	59.03	8.38	0.80	1.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	68.08	12.83	0.00	1.48	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	73.19	12.98	1.18	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	55.43	8.75	2.33	2.33	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.88	9.22	0.88	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	49.17	9.32	1.70	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.83	10.74	1.19	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	32.03	8.25	0.97	0.97	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	5.71	0.00	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.05	7.07	0.42	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	29.24	7.87	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	27.28	6.34	0.32	1.59	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	41.77	13.79	2.51	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	26.57	10.68	3.25	2.44	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	31.06	8.44	3.21	1.69	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	27.98	9.56	3.87	2.05	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.61	13.99	3.39	3.17	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.44	13.97	3.01	2.36	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	27.77	13.13	3.88	3.44	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	24.53	9.59	2.86	1.74	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	24.19	7.55	3.77	1.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.95	8.01	3.52	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	33.58	5.04	1.12	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.91	4.76	0.43	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	5.29	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	33.86	8.47	2.47	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	30.51	10.90	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	31.30	8.39	1.57	0.52	0.35
Hepatocyte, donor1	11523-119I2	32.69	10.90	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	52.79	16.16	3.23	6.46	0.00
Hepatocyte, donor3	11684-122I1	24.54	6.14	1.84	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	29.37	5.22	1.31	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.62	9.96	1.92	1.05	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.78	7.68	0.96	0.69	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	22.29	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	45.68	13.84	1.38	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	52.56	20.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	71.21	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	79.45	23.07	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	9.14	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	42.23	32.49	4.87	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	23.34	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	65.35	21.78	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	64.85	29.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	38.80	21.06	1.11	4.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	110.00	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	32.12	22.05	2.52	1.89	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	46.40	21.65	3.09	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	56.21	25.20	4.52	1.94	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	46.69	14.49	1.61	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	45.63	29.34	1.63	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	44.50	34.84	2.94	2.94	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	52.24	20.09	6.43	4.82	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	27.70	19.39	0.92	4.62	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	15.08	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.99	20.77	1.89	3.78	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	39.91	29.02	0.00	3.63	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	37.66	24.75	1.08	5.38	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	49.55	40.65	1.27	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.99	24.23	4.46	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	38.28	34.63	5.47	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	45.70	24.99	3.57	5.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	23.23	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	44.45	20.68	2.47	4.32	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	19.32	1.76	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	22.00	0.00	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	49.37	14.60	2.78	3.48	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	11.07	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	74.57	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	46.21	11.34	6.10	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	58.49	20.25	6.75	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	27.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	73.61	19.20	3.20	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	54.03	15.24	0.00	5.54	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	28.50	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	13.81	4.60	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	105.89	21.18	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	18.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	84.59	19.03	0.00	3.17	1.06
Keratinocyte - epidermal, donor1	11272-116H3	13.55	6.77	1.80	1.06	0.08
Keratinocyte - epidermal, donor2	11349-117G8	36.90	9.37	2.34	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	26.69	8.90	1.51	0.47	0.00
Keratinocyte - oral, donor1	11251-116E9	36.44	10.22	1.25	0.91	0.11
Keratocytes, donor1	11527-119I6	48.48	18.57	1.72	3.44	0.34
Keratocytes, donor2	11607-120I5	38.67	10.55	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	33.00	5.93	0.99	0.99	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	23.73	8.63	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	30.91	8.88	0.69	0.58	0.00
Lens Epithelial Cells, donor3	11690-122I7	18.97	5.65	0.71	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.43	4.74	0.71	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	23.44	4.47	1.40	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	20.94	4.88	0.94	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	18.28	3.76	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.28	4.73	0.32	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	22.64	5.07	0.43	0.32	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.29	4.51	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	22.75	3.29	0.76	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.58	3.52	1.13	0.70	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.80	4.75	0.79	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.78	3.88	0.58	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	23.51	5.18	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.21	2.44	1.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.41	2.86	0.24	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	19.09	5.22	0.69	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	18.17	4.93	0.92	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	21.51	3.43	0.94	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.96	4.94	1.10	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	17.44	2.30	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	19.33	4.10	0.59	0.88	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.66	6.47	1.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.28	3.39	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	18.31	4.85	0.54	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	17.71	5.75	0.30	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	15.55	6.22	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.54	5.44	0.42	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	16.99	6.17	0.90	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	4.82	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.99	6.02	1.13	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	19.62	5.62	0.32	0.64	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.23	8.72	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.18	7.61	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.96	5.82	0.74	0.62	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.51	5.55	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.30	6.42	0.99	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.22	4.81	0.27	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.76	6.43	0.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	19.48	5.48	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.62	3.36	0.98	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	18.84	2.49	1.07	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.51	5.82	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	19.30	5.45	0.47	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	24.71	9.67	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.95	2.94	0.33	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.78	4.94	1.18	0.94	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	27.23	6.68	1.36	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.70	4.61	0.51	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	24.17	5.37	0.60	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	61.18	20.39	0.00	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	57.53	9.97	2.30	3.07	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	58.64	15.59	2.97	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	51.62	13.54	2.96	2.12	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	54.86	11.96	2.11	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	61.64	7.47	6.54	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	47.92	10.82	3.61	3.61	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	58.28	16.65	0.00	5.95	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	61.98	18.32	2.26	3.62	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	35.48	12.80	0.29	3.49	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	50.87	10.80	1.80	1.80	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	52.84	22.22	3.12	3.66	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	45.19	14.38	2.05	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.52	11.64	1.76	2.47	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	43.31	14.66	1.33	6.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	46.86	19.87	6.11	5.09	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	47.22	16.81	1.87	2.93	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	49.13	21.54	2.46	4.72	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	38.65	19.63	3.07	3.07	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	75.83	17.94	2.45	4.08	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	43.73	20.62	1.87	3.33	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	39.24	24.94	2.52	3.36	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	48.43	21.64	2.06	4.12	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.58	21.48	3.77	4.06	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	36.77	22.42	1.49	3.89	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	43.15	16.04	3.32	7.19	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	48.43	25.45	1.77	3.18	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	41.67	23.97	2.95	3.32	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	55.26	19.57	3.45	6.91	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	58.33	28.78	4.61	3.84	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.06	27.17	3.96	5.10	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	49.23	25.43	3.28	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	48.80	24.85	3.16	4.52	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	52.42	18.67	1.44	5.03	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	37.35	21.66	2.24	5.23	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	48.68	22.30	0.37	2.60	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	37.91	21.97	0.43	2.58	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	46.24	17.98	0.86	5.14	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	49.31	19.32	2.33	5.00	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	45.85	16.89	2.41	4.22	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	58.30	19.20	1.42	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	40.21	19.25	1.72	2.41	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	56.36	14.49	1.61	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	59.26	20.20	3.37	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	45.93	19.26	1.85	4.07	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	45.35	24.42	2.33	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	60.29	28.56	2.12	6.35	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	48.42	22.01	3.60	3.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	55.24	13.81	6.54	4.36	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	93.52	18.40	2.30	5.37	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	59.69	14.31	1.48	5.43	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.05	13.17	2.82	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	71.40	16.09	4.53	5.03	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	56.78	18.93	4.51	4.06	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	53.35	25.82	3.44	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	70.81	27.61	2.23	4.01	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	55.53	20.72	2.74	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	46.84	12.53	1.32	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	76.28	28.02	3.63	7.26	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	58.63	19.25	2.19	5.25	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	53.11	16.21	2.80	3.35	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	60.50	27.38	3.09	6.18	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	52.84	26.23	3.86	5.79	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	45.07	21.77	3.04	1.52	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	59.60	27.40	1.92	7.21	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	61.22	20.27	3.58	4.37	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	35.85	13.98	2.43	4.25	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.73	12.45	0.69	5.53	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	45.98	27.74	2.28	7.22	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	35.12	34.08	0.52	7.23	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	53.21	23.58	3.63	6.05	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	51.34	26.62	3.49	6.34	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	43.18	36.25	1.60	8.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	63.21	33.91	4.60	8.05	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	50.39	38.57	5.14	6.69	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	41.03	39.61	1.41	4.95	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	50.51	38.59	2.84	10.21	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	45.35	39.94	1.66	7.07	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	31.32	23.49	1.57	7.05	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	37.58	35.91	4.18	11.69	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.25	36.71	2.32	8.83	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.10	28.77	1.34	10.04	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.03	32.61	4.81	9.09	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	44.05	36.37	3.64	6.47	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	39.46	28.45	3.67	4.59	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	46.23	23.12	2.67	10.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	43.88	30.20	3.42	5.70	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	46.78	32.21	4.60	3.07	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.28	22.98	2.19	6.57	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	50.34	27.62	2.23	6.68	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	44.71	34.05	3.64	7.02	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	53.71	18.57	1.99	2.65	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	49.89	12.47	0.00	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	19.37	2.28	1.60	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	12.66	8.81	1.65	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	15.34	4.85	1.05	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	32.92	12.74	3.72	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	18.06	5.70	1.58	1.58	0.48
Mallassez-derived cells, donor3	11930-125I4	18.07	7.09	2.08	0.69	0.14
Mammary Epithelial Cell, donor1	11273-116H4	23.52	11.56	2.49	0.70	0.00
Mammary Epithelial Cell, donor2	11350-117G9	25.77	7.53	1.74	2.03	0.00
Mammary Epithelial Cell, donor3	11422-118F9	35.92	8.48	1.50	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	3.39	10.17	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	22.28	4.65	1.30	0.65	0.22
Mast cell, donor2	11565-120D8	23.48	4.75	2.97	0.00	0.59
Mast cell, donor3	11566-120D9	19.81	4.28	2.70	1.13	0.23
Mast cell, donor4	11567-120E1	29.08	2.66	2.84	0.71	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	19.18	6.43	0.78	0.78	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	11.67	9.34	0.58	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	25.93	4.13	1.38	0.23	0.80
Mast cell, expanded, donor8	11941-126A6	23.10	1.34	0.84	0.17	1.00
Melanocyte - dark, donor1	11502-119F8	31.84	7.16	0.70	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	34.95	10.73	2.08	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	29.77	11.66	1.74	1.30	0.22
Melanocyte - light, donor1	11274-116H5	19.51	9.40	0.71	1.65	0.24
Melanocyte - light, donor2	11351-117H1	37.54	8.87	2.05	0.00	0.68
Melanocyte - light, donor3	11423-118G1	17.34	6.94	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	37.07	14.16	2.81	1.25	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	25.55	18.29	2.69	2.96	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	27.05	8.04	1.34	0.54	0.80
Meningeal Cells, donor1	11493-119E8	32.75	8.68	1.49	0.87	0.00
Meningeal Cells, donor2	11573-120E7	17.17	7.04	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	20.29	11.90	0.98	0.65	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.06	19.11	1.43	1.71	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.76	5.94	1.01	0.70	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	82.79	9.20	1.31	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	43.17	22.24	3.92	5.23	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	18.66	0.00	2.87	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.64	5.72	1.69	1.06	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.57	4.52	2.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	34.94	14.06	3.08	1.98	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	28.49	9.50	0.73	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	25.17	14.73	3.07	2.05	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	45.57	6.23	1.52	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	44.24	11.90	2.23	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.16	9.87	1.84	0.92	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	82.49	21.07	3.56	3.26	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.05	12.81	0.64	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.74	15.95	1.77	2.84	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.21	7.82	1.88	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	35.56	7.98	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	15.38	6.10	1.59	0.80	0.53
Mesothelial Cells, donor2	12156-128G5	18.52	7.01	1.50	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.27	4.26	1.23	0.43	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	8.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.07	2.71	1.23	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.60	7.66	0.59	1.47	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.19	3.72	1.24	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.02	6.22	1.24	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.52	4.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	7.91	0.00	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.97	4.06	0.41	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.09	5.94	1.19	2.38	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.88	7.22	1.14	2.28	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	2.63	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.10	4.46	1.06	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	2.76	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.54	5.07	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	6.71	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.04	4.01	0.75	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.13	4.52	0.24	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.22	2.99	1.38	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.36	5.26	1.05	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.32	2.85	1.43	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.58	5.58	1.07	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.00	4.45	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.91	3.50	1.10	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.04	2.53	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.53	4.08	1.09	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.76	5.88	1.47	1.47	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.57	5.29	0.96	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	8.40	0.40	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	4.11	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.02	5.51	2.00	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.26	4.38	0.44	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	3.31	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.64	5.70	1.74	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	4.87	0.00	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.02	4.79	1.37	2.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.13	4.38	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.30	1.78	1.07	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	19.64	5.33	1.68	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	4.99	0.42	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	2.33	0.58	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.07	3.62	2.71	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.43	10.85	0.83	0.83	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	11.08	5.54	2.77	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.11	5.12	1.14	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.23	3.59	0.28	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	16.33	5.96	1.81	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.73	7.29	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.21	2.94	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.27	10.78	2.39	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.02	3.67	1.41	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.07	6.69	2.55	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.49	10.17	3.10	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.69	1.14	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	17.05	5.97	2.27	0.85	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.89	7.37	3.20	0.74	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	3.26	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.06	5.00	0.88	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	21.34	9.80	1.73	1.44	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	10.30	5.77	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.97	2.98	1.49	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	5.35	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.43	4.27	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	6.31	2.10	3.16	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.36	2.57	1.78	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	5.59	3.73	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.39	1.13	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.92	5.86	1.07	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.49	3.96	1.81	0.34	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	0.74	1.47	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.12	1.47	1.10	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	6.22	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	17.64	4.28	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	2.95	2.11	0.84	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	0.81	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	3.02	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	22.84	5.71	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	22.84	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.11	7.32	0.65	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	3.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.00	2.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.84	2.09	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.31	5.13	1.71	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	9.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	2.04	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.88	2.51	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	10.23	3.49	1.16	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.89	0.81	0.54	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.30	2.10	0.21	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	0.50	0.50	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.41	3.52	0.00	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.65	1.36	1.13	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.96	2.94	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.11	2.92	0.55	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	2.65	1.59	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	2.40	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	8.86	4.59	0.00	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.94	0.98	0.81	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	10.41	2.47	0.18	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	2.11	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.95	0.46	0.46	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.57	2.57	0.96	0.32	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.76	2.41	1.03	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	5.06	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.69	1.34	0.67	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.23	5.08	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.29	2.85	0.71	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	5.58	0.86	0.86	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	2.67	0.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	3.16	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.14	2.38	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	1.86	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.00	5.68	0.76	1.51	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.80	1.63	0.65	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	3.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	6.78	4.52	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	2.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	12.63	3.32	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.90	2.48	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.13	1.15	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.73	6.35	0.91	1.51	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.84	4.20	0.66	1.77	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.10	3.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	3.05	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.50	3.15	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.80	2.42	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	2.37	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	0.00	1.13	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	18.63	12.42	4.35	1.99	0.12
Myoblast, donor2	11322-117D8	22.06	8.82	1.53	0.77	0.58
Myoblast, donor3	11398-118D3	23.04	12.44	1.18	1.68	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	41.01	4.67	1.02	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	23.68	4.31	0.92	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	17.19	1.51	1.51	1.21	0.00
Natural Killer Cells, donor3	11387-118C1	24.85	4.97	0.74	1.10	0.37
Neural stem cells, donor1	11275-116H6	7.62	15.97	1.09	0.73	0.73
Neural stem cells, donor2	11352-117H2	9.63	9.63	1.93	3.85	1.93
Neurons, donor1	11494-119E9	25.03	18.21	1.14	3.41	0.00
Neurons, donor2	11574-120E8	24.88	7.71	0.88	0.88	0.00
Neurons, donor3	11655-122E8	18.91	14.80	0.82	3.29	0.00
Neutrophils, donor1	11233-116C9	11.14	0.93	2.78	0.93	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.72	2.44	1.83	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	40.37	10.92	1.19	1.42	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	48.51	7.16	1.30	1.30	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	37.50	11.43	1.40	1.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	16.11	4.27	0.69	0.69	0.14
Olfactory epithelial cells, donor2	11934-125I8	18.24	6.66	0.87	0.58	0.29
Olfactory epithelial cells, donor3	11935-125I9	16.57	4.31	1.36	0.34	0.34
Olfactory epithelial cells, donor4	11936-126A1	15.10	3.60	0.49	0.29	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	22.27	13.24	2.41	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	22.12	8.93	1.49	1.06	0.64
Osteoblast - differentiated, donor2	11353-117H3	25.15	9.14	3.43	1.14	3.43
Osteoblast - differentiated, donor3	11425-118G3	65.17	13.03	3.72	2.48	1.24
Osteoblast, donor1	11277-116H8	26.19	8.99	1.37	0.59	0.00
Osteoblast, donor2	11354-117H4	19.66	2.81	2.11	0.00	0.00
Osteoblast, donor3	11426-118G4	16.88	8.18	0.53	1.42	0.36
Pancreatic stromal cells, donor1	11249-116E7	17.86	8.17	1.01	1.10	0.25
Pericytes, donor1	11491-119E6	38.39	7.68	0.89	1.00	0.33
Pericytes, donor2	11571-120E5	29.43	4.98	0.91	1.36	0.23
Pericytes, donor3	11652-122E5	25.43	13.22	0.41	0.61	0.00
Perineurial Cells, donor1	11499-119F5	27.80	7.80	0.45	0.34	0.00
Perineurial Cells, donor2	11579-120F4	34.04	11.32	1.29	0.83	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	20.08	1.59	1.27	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	13.47	1.47	0.00	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.57	1.81	0.13	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	52.38	24.87	5.02	2.87	1.20
Placental Epithelial Cells, donor2	11355-117H5	39.92	9.98	5.54	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	45.55	10.41	1.77	0.98	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.35	8.54	1.90	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	16.70	7.32	2.81	0.56	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.66	1.96	0.65	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	18.24	6.98	2.25	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	17.48	7.25	2.24	0.64	1.28
Preadipocyte - omental, donor2	11329-117E6	15.28	8.73	0.44	1.75	0.87
Preadipocyte - omental, donor3	11403-118D8	15.47	8.02	1.43	0.86	0.29
Preadipocyte - perirenal, donor1	11469-119C2	31.50	11.81	5.91	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.51	7.37	0.61	1.23	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	16.82	10.09	1.42	1.24	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	14.13	13.62	1.70	1.36	0.68
Preadipocyte - visceral, donor1	11280-116I2	15.46	9.50	1.68	0.65	0.28
Preadipocyte - visceral, donor2	11357-117H7	12.42	7.36	0.92	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	15.78	7.63	1.15	0.63	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.02	13.58	0.75	2.87	1.36
Prostate Epithelial Cells, donor2	11331-117E8	15.44	6.09	2.03	1.22	0.54
Prostate Epithelial Cells, donor3	11404-118D9	9.74	2.39	0.55	0.12	0.12
Prostate Stromal Cells, donor1	11254-116F3	20.05	9.23	1.82	0.91	0.11
Prostate Stromal Cells, donor2	11332-117E9	22.95	7.17	1.43	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	19.60	7.40	1.04	1.36	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	32.48	3.28	1.46	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.21	5.34	1.04	0.55	0.21
Renal Epithelial Cells, donor1	11517-119H5	30.43	4.57	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	26.32	5.69	2.13	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.97	7.83	0.74	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	16.34	6.13	1.36	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	29.11	4.18	0.27	1.08	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.20	3.55	1.33	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	14.64	3.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	29.49	9.02	1.10	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	29.47	8.78	0.63	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	25.80	7.49	1.11	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	27.65	5.10	1.34	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.07	2.95	1.69	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.16	6.94	2.12	1.35	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	33.97	6.22	1.30	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	38.66	6.82	0.57	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	9.26	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.33	8.28	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.99	6.01	1.20	0.94	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	4.47	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	5.50	2.20	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	4.06	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.61	3.64	0.13	1.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.42	3.48	0.30	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	14.72	4.80	0.89	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	17.24	3.35	0.74	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.85	4.31	0.47	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.64	3.93	0.46	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.69	2.46	0.41	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.46	2.42	0.45	0.76	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.64	3.94	0.18	1.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.35	4.02	0.86	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.84	5.04	0.64	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	15.27	5.09	1.55	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.47	2.29	0.57	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	9.97	3.45	0.37	0.75	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.65	3.76	0.19	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.34	1.86	0.93	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	9.54	4.38	0.78	0.19	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.47	4.77	0.95	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.78	2.56	0.75	0.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.49	2.52	1.12	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	11.79	3.25	0.34	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	8.39	1.64	0.55	1.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	10.67	3.07	0.25	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	15.18	4.57	0.54	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	16.28	3.07	0.24	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	14.48	5.36	1.39	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	15.43	5.38	0.94	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.55	3.94	1.04	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	9.07	3.98	0.88	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	8.56	4.18	0.84	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.42	3.63	1.21	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	10.05	3.92	1.02	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	11.18	3.08	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	13.58	2.06	0.17	0.52	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.68	2.61	0.14	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	7.39	3.45	0.49	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.93	3.41	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.28	4.14	0.15	0.59	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	7.73	1.87	0.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	13.14	2.90	0.41	0.83	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.43	5.48	0.48	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	11.69	4.03	0.60	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.82	3.01	0.57	1.32	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	16.07	2.45	0.35	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.07	3.63	0.60	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	13.46	3.43	0.49	0.49	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	13.97	4.95	0.73	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.90	4.26	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	13.26	2.71	0.30	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	18.77	7.24	0.68	1.81	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	11.08	6.59	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	23.14	5.90	0.71	1.53	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.13	10.03	0.43	0.43	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	16.23	5.41	1.80	0.00	0.00
Schwann Cells, donor1	11498-119F4	29.15	4.89	1.13	0.56	0.56
Schwann Cells, donor2	11578-120F3	34.02	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	27.17	4.82	1.75	0.22	0.00
Sebocyte, donor1	11220-116B5	20.82	9.86	1.64	2.19	0.00
Sebocyte, donor2	11301-117B5	12.87	5.06	2.30	0.00	0.00
Sebocyte, donor3	11378-118B1	18.55	3.50	1.24	0.41	0.21
Sertoli Cells, donor1	11255-116F4	19.88	6.63	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	5.65	8.47	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	23.84	7.21	1.06	0.70	0.62
Skeletal Muscle Cells, donor2	11358-117H8	28.91	2.89	2.17	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	30.93	10.87	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.49	25.45	2.67	5.34	0.16
Skeletal Muscle Cells, donor5	11455-119A6	26.01	24.38	2.08	4.76	0.45
Skeletal Muscle Cells, donor6	11459-119B1	23.55	13.85	1.08	0.92	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	54.43	18.65	2.14	2.27	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.52	16.55	2.85	2.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.99	18.06	2.38	2.08	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	15.67	6.32	1.18	0.93	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	21.71	9.41	2.17	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.96	4.13	0.55	0.14	0.28
Skin - palm, donor1	10286-104F7	8.06	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.73	4.18	1.87	0.72	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.99	4.91	2.45	3.27	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.02	3.25	1.56	0.39	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	14.32	6.26	1.25	0.28	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	9.99	3.80	1.27	1.13	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	17.76	8.67	1.48	1.27	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	10.49	2.92	1.50	0.22	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.05	1.85	0.00	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.45	3.78	0.89	1.33	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	16.46	8.82	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.91	5.52	1.33	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.14	5.51	1.97	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	22.40	2.32	1.55	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	51.04	8.01	0.00	3.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.77	3.59	1.60	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.29	9.53	1.11	1.33	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.34	4.10	0.90	0.64	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	29.30	8.79	1.30	0.98	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.26	11.81	1.77	1.18	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	20.07	8.40	1.71	1.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	31.23	9.44	3.42	1.30	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.01	9.13	1.83	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.53	5.81	1.77	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.50	3.81	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.20	9.44	1.47	0.59	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.97	6.03	1.72	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	22.04	6.61	1.36	0.63	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.93	4.18	1.86	0.46	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	6.47	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.84	2.09	1.79	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.38	8.88	0.68	2.05	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	40.36	8.48	2.04	0.63	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.27	7.15	1.01	0.70	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.71	6.14	1.82	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.70	4.83	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.12	13.51	2.91	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.90	4.26	2.40	0.27	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.78	5.13	1.38	0.38	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.58	3.04	1.52	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.04	7.39	0.60	0.90	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	6.00	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	2.58	2.58	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.18	3.72	1.40	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	15.15	7.07	0.00	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.60	6.58	1.25	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.37	7.67	2.36	1.47	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	29.82	12.58	3.00	0.75	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	31.30	3.74	1.87	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.52	3.89	1.73	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.59	5.61	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.73	4.51	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	23.20	5.45	1.68	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	33.85	8.04	2.43	0.92	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.09	1.90	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.70	3.67	1.22	0.49	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	14.36	10.83	1.33	1.10	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	17.26	7.90	1.17	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.27	4.86	0.78	0.97	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.05	2.38	0.79	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	5.58	1.49	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.20	6.47	1.44	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.22	6.81	1.70	1.99	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.09	5.91	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	13.97	4.06	0.25	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	18.77	7.59	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	17.97	6.27	1.25	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	31.17	6.88	2.29	0.00	0.46
Synoviocyte, donor1	11291-117A4	9.59	10.60	2.02	1.85	0.84
Synoviocyte, donor2	11368-117I9	27.32	6.20	1.51	0.34	0.50
Synoviocyte, donor3	11440-118H9	28.60	3.13	1.12	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	35.02	12.86	1.79	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	13.87	1.98	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	31.72	10.65	1.62	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	14.41	3.51	0.93	0.43	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	22.81	9.66	1.16	1.55	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	17.18	8.02	1.15	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	25.59	7.01	2.34	0.37	0.37
Urethra, donor2	10319-105A4	8.99	7.19	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	24.18	5.84	2.39	0.53	0.27
Urothelial Cells, donor2	11600-120H7	15.62	5.61	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	18.57	5.73	1.15	0.69	0.00
Urothelial cells, donor0	11216-116B1	18.05	5.13	1.11	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	39.15	1.78	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	42.89	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	1.37	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	18.94	1.72	1.38	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	24.40	2.32	1.16	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	38.53	2.08	1.04	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	2.75	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	20.08	1.83	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	24.92	6.78	1.48	1.23	0.25
Wilms' tumor cell line:HFWT	10597-108E3	11.44	8.80	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	27.93	3.35	1.40	0.28	0.00
achilles tendon, donor2	10292-104G4	10.33	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	33.91	7.65	0.51	1.27	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	31.58	6.27	1.39	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	18.99	2.02	0.71	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	35.92	7.35	2.18	0.54	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	45.54	8.15	2.53	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	63.02	8.46	3.60	1.06	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	18.24	1.36	1.09	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	38.78	3.53	1.76	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	38.39	2.04	0.82	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	33.78	5.82	2.33	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.50	5.15	2.02	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	66.31	7.80	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	37.18	5.34	0.23	0.93	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	24.34	2.85	1.04	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	36.82	2.63	1.46	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	23.24	0.93	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	19.74	6.58	1.23	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	32.84	5.22	0.31	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	36.27	5.55	2.99	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	37.91	5.46	1.82	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	35.87	4.81	3.61	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	23.83	3.79	2.23	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.34	10.01	0.33	1.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	3.72	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	39.17	15.07	1.88	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	26.60	2.18	0.87	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	23.55	4.47	1.18	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	20.94	5.89	0.62	1.40	0.16
adipose, donor1	10184-103D4	60.40	16.42	2.35	2.93	5.28
adipose, donor2	10185-103D5	32.04	5.27	0.00	1.22	5.27
adipose, donor3	10186-103D6	20.42	10.07	0.82	4.08	4.90
adipose, donor4	10187-103D7	25.14	2.60	0.87	1.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.78	4.26	0.79	0.63	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	10.91	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.62	4.14	3.20	0.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	19.65	3.57	1.79	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	43.59	9.27	2.78	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	42.94	11.16	2.37	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	37.12	6.19	2.65	1.18	0.29
amygdala - adult, donor10196	10167-103B5	7.11	5.93	1.19	2.37	0.00
amygdala, adult, donor10252	10151-102I7	13.18	3.24	0.41	1.22	0.00
amygdala, newborn, donor10223	10360-105E9	10.01	7.42	0.97	3.87	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	36.29	7.39	0.76	0.89	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	26.25	6.62	1.99	0.88	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	22.05	7.35	1.34	0.67	0.00
aorta, adult, pool1	10052-101G7	13.73	1.77	0.98	0.39	0.20
appendix, adult	10189-103D9	21.73	3.49	0.39	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.86	15.82	1.38	1.72	0.69
artery, adult	10190-103E1	19.02	1.36	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	17.53	7.39	0.14	0.87	0.00
b cell line:RPMI1788	10427-106D4	33.16	4.76	0.59	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.04	6.38	1.11	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.91	2.88	0.20	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	35.48	11.88	1.84	1.84	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	43.06	1.12	1.12	1.12	0.00
bladder, adult, pool1	10011-101C2	20.32	2.50	1.09	0.76	0.00
blood, adult, pool1	10053-101G8	15.50	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	9.42	1.71	0.00	0.86
bone marrow, adult	10192-103E3	16.87	2.02	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	11.28	12.30	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	9.13	4.79	1.11	1.34	0.22
brain, fetal, pool1	10085-102B4	32.06	2.67	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	36.67	5.62	1.65	1.65	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	17.35	5.12	1.00	0.37	0.00
breast, adult, donor1	10080-102A8	17.68	3.16	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.37	2.54	2.16	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	20.10	4.95	1.55	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	19.34	9.44	3.22	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.38	1.94	0.48	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	19.75	3.29	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	15.64	3.28	0.88	0.33	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	24.08	6.02	0.63	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.35	7.99	0.27	2.13	0.00
caudate nucleus - adult, donor10196	10177-103C6	5.76	3.45	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	11.21	6.86	0.84	1.34	0.00
caudate nucleus, adult, donor10258	10379-105H1	12.23	9.17	1.53	3.82	0.00
caudate nucleus, newborn, donor10223	10354-105E3	11.72	10.25	0.73	5.13	0.73
cerebellum - adult, donor10196	10173-103C2	11.65	5.83	0.00	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	16.23	8.11	1.07	1.49	0.43
cerebellum, adult, pool1	10083-102B2	11.04	9.66	0.69	2.76	0.00
cerebellum, newborn, donor10223	10357-105E6	18.27	4.98	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	10.34	4.79	1.01	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	8.77	3.65	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	41.12	9.78	1.15	1.73	0.43
cervical cancer cell line:ME-180	10553-107I4	18.89	7.79	0.66	0.33	0.00
cervix, adult, pool1	10013-101C4	23.94	5.04	1.26	0.63	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	29.26	14.35	0.98	3.07	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	13.06	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	27.34	8.33	0.99	0.87	0.62
choriocarcinoma cell line:SCH	10785-110H2	49.65	13.06	1.60	0.86	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	19.45	5.22	1.42	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	39.03	7.41	3.42	1.71	1.14
chorionic membrane cells, donor2	12239-129G7	32.91	11.04	1.39	1.29	1.39
chorionic membrane cells, donor3	12240-129G8	46.71	12.09	3.30	2.75	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	11.11	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.78	9.60	0.58	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.75	4.01	0.21	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	26.71	9.50	1.03	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	28.06	9.43	1.45	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	25.45	14.66	0.81	1.02	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	28.56	12.37	2.36	1.47	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	26.58	5.73	1.56	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.80	6.63	1.60	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	11.28	2.60	1.21	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	23.61	11.17	1.28	1.28	0.37
colon carcinoma cell line:COLO-320	10420-106C6	41.05	8.74	3.04	0.38	0.38
colon, adult, donor1	10082-102B1	33.32	3.57	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	35.60	9.05	2.47	1.76	0.47
colon, fetal, donor1	10070-101I7	19.78	2.47	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	41.25	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	17.00	20.82	1.27	2.55	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.38	18.26	1.51	2.26	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	20.87	22.98	0.85	1.83	0.00
corpus callosum, adult, pool1	10042-101F6	18.46	9.18	1.99	1.99	0.11
cruciate ligament, donor2	10295-104G7	10.54	4.05	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	18.46	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	9.60	5.04	0.96	2.16	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.49	2.76	1.15	0.92	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	17.69	4.87	1.54	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.35	8.18	1.20	1.20	0.48
ductus deferens, adult	10196-103E7	22.43	3.49	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	2.88	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.10	5.89	0.74	0.74	0.74
dura mater, adult, donor1	10041-101F5	14.45	2.64	1.24	0.17	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.21	25.54	1.33	2.89	3.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.34	9.89	2.29	1.15	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	25.90	6.17	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	26.64	3.63	2.12	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	31.49	8.64	1.54	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	42.03	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	17.43	16.42	1.34	2.35	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.07	5.62	1.27	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	19.46	7.88	1.61	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	7.45	3.11	0.22	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.76	3.30	0.77	0.22	0.00
epididymis, adult	10197-103E8	14.02	4.81	1.47	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	22.18	7.81	1.42	1.60	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.22	3.93	2.36	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	42.98	11.66	1.97	1.97	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	36.22	7.18	1.97	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	44.14	10.19	2.13	2.58	0.00
esophagus, adult, pool1	10015-101C6	16.56	1.38	0.85	0.42	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.03	7.51	0.63	1.63	0.13
eye - muscle inferior rectus, donor1	10272-104E2	14.49	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	2.98	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	5.73	4.59	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	4.37	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	23.14	5.34	0.25	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	16.41	3.59	0.77	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	17.33	5.46	0.71	1.42	0.47
frontal lobe, adult, pool1	10040-101F4	10.51	6.94	1.22	1.41	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	30.02	10.51	1.80	0.90	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.33	3.20	0.82	0.27	0.27
gall bladder, adult	10198-103E9	19.07	4.83	1.21	1.45	0.00
gamma delta positive T cells, donor1	11937-126A2	42.41	2.68	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	35.48	3.36	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	27.67	8.24	3.17	2.75	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	58.22	11.80	3.48	1.35	0.19
gastric cancer cell line:AZ521	10549-107H9	33.45	16.72	2.79	2.62	0.16
gastric cancer cell line:GSS	10560-108A2	47.59	3.66	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.33	15.31	0.23	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	12.16	4.70	0.57	0.57	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	31.77	9.52	2.38	0.84	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.96	6.24	1.75	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	13.83	5.17	0.84	1.48	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	13.76	4.77	0.70	1.12	0.14
glioblastoma cell line:T98G	10485-107A8	18.54	4.53	1.21	0.55	0.11
glioma cell line:GI-1	10413-106B8	17.28	6.44	1.17	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	12.39	3.64	0.00	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	17.57	2.20	0.98	2.20	0.00
globus pallidus, adult, donor10258	10367-105F7	8.22	6.85	1.37	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.66	7.99	0.53	2.66	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	7.68	2.24	0.64	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	17.45	11.02	0.92	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	21.03	6.40	1.37	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	36.07	7.09	0.00	3.22	0.00
hIPS, biol_rep1	14380-156B6	28.75	8.62	1.44	2.87	0.00
hIPS, biol_rep2	14381-156B7	22.63	7.54	0.00	2.06	0.69
hIPS, biol_rep3	14382-156B8	13.24	8.83	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	17.53	6.90	1.15	0.29	0.00
heart - mitral valve, adult	10205-103F7	11.96	2.39	0.30	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	10.98	4.71	1.57	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	16.65	5.00	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	18.98	8.37	0.41	0.82	1.02
heart, adult, diseased, donor1	10051-101G6	15.76	6.39	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	15.41	3.22	1.15	1.38	0.00
heart, fetal, pool1	10046-101G1	20.33	4.11	0.92	0.62	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.80	3.39	1.23	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	32.11	10.70	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.67	24.42	0.99	5.08	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.66	24.64	0.73	4.73	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.11	21.73	0.81	4.35	0.10
hepatoma cell line:Li-7	10484-107A7	21.24	14.57	0.67	1.56	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	29.15	6.03	1.31	1.61	0.00
hippocampus - adult, donor10196	10169-103B7	10.41	1.89	0.95	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	11.84	5.71	1.63	1.63	0.00
hippocampus, adult, donor10258	10374-105G5	17.93	5.48	0.50	2.99	0.00
hippocampus, newborn, donor10223	10363-105F3	7.75	6.34	0.70	3.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	30.52	10.99	1.83	1.83	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.38	11.58	1.37	1.18	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	20.82	9.90	0.76	2.29	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	39.47	12.97	1.69	2.26	8.46
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	36.92	17.30	1.81	2.84	9.04
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	43.28	17.08	1.14	1.90	6.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	30.66	10.22	1.75	1.75	7.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	30.81	13.57	1.08	2.59	8.19
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	31.70	11.68	1.25	2.09	4.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	34.57	12.79	0.95	1.89	3.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	26.68	13.66	0.96	2.25	4.02
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.03	10.10	1.35	2.69	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.62	8.45	1.25	2.03	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.06	4.91	0.98	1.47	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.07	8.73	0.87	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	43.91	15.85	1.34	1.72	7.25
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	35.76	14.83	0.44	1.74	9.59
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	59.97	18.99	0.00	2.00	10.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.23	9.23	0.94	2.45	5.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.47	10.46	1.36	0.91	8.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	29.44	8.77	1.57	2.19	5.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.03	14.70	0.49	3.43	5.72
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	32.80	13.35	0.58	2.61	5.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	27.50	14.95	0.90	3.89	6.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.80	12.93	0.55	4.25	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.39	16.26	0.57	4.56	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	33.89	18.78	0.82	2.45	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	43.66	12.32	2.82	2.11	7.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.01	13.30	0.95	0.95	7.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	43.27	21.18	0.61	3.63	7.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	39.82	9.83	1.03	2.07	5.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	35.86	6.64	0.00	0.66	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	27.96	10.52	0.77	1.80	3.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	37.58	9.97	1.28	2.56	4.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.92	9.09	1.51	2.27	8.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	24.20	9.75	1.01	2.02	5.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.91	13.52	0.97	2.42	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	30.75	15.15	1.34	5.79	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	24.39	10.73	0.49	2.93	5.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	39.12	19.56	0.61	1.53	7.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	55.31	29.28	0.00	3.25	35.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	52.62	14.89	0.99	1.32	8.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	38.31	9.85	0.55	1.09	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	39.81	10.49	2.17	2.17	6.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.88	9.96	1.07	1.42	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	25.06	7.16	1.19	0.00	10.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	38.73	11.92	1.22	0.95	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	23.98	8.62	0.27	1.08	2.96
immature langerhans cells, donor1	11904-125F5	13.56	3.63	2.18	0.24	0.24
immature langerhans cells, donor2	11905-125F6	10.30	0.79	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	11.36	8.61	1.14	2.27	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	13.01	1.95	0.65	0.00	0.33
kidney, adult, pool1	10017-101C8	24.93	5.51	2.90	1.50	0.30
kidney, fetal, pool1	10045-101F9	28.51	6.93	1.77	1.56	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.45	8.38	0.85	1.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	24.75	5.39	1.24	0.69	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.40	3.30	1.10	0.55	0.00
left atrium, adult, donor1	10079-102A7	11.44	2.72	0.54	0.00	1.09
left ventricle, adult, donor1	10078-102A6	11.12	3.03	2.53	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	15.60	5.75	1.37	1.37	0.00
leiomyoma cell line:10964C	10569-108B2	13.65	5.75	2.16	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	11.96	1.09	1.63	0.00	0.00
leiomyoma cell line:15425	10571-108B4	9.96	2.19	1.94	0.24	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	25.40	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	5.23	6.27	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	23.97	12.04	0.71	1.53	0.12
liposarcoma cell line:KMLS-1	10782-110G8	9.84	2.34	1.09	0.78	0.16
liposarcoma cell line:SW 872	10726-110A6	17.91	5.60	0.85	1.10	0.00
liver, adult, pool1	10018-101C9	29.01	13.61	3.08	3.08	0.65
liver, fetal, pool1	10086-102B5	17.87	6.58	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	7.73	3.65	0.58	0.73	0.15
locus coeruleus, adult, donor10252	10165-103B3	14.76	5.91	0.92	1.66	0.18
locus coeruleus, adult, donor10258	10375-105G6	10.44	5.08	0.56	2.54	0.28
locus coeruleus, newborn, donor10223	10362-105F2	4.63	3.79	1.26	2.10	0.42
lung adenocarcinoma cell line:A549	10499-107C4	24.63	4.57	2.08	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	36.54	4.14	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	12.13	1.85	0.66	0.00	0.00
lung, adult, pool1	10019-101D1	19.49	2.24	1.54	0.12	0.12
lung, fetal, donor1	10068-101I5	27.11	2.28	1.43	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	13.75	2.75	1.37	0.00	0.00
lymph node, adult, donor1	10077-102A5	18.93	2.37	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	16.88	1.97	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	9.96	2.26	0.00	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	6.80	0.85	0.85	0.00
mature adipocyte, donor1	12231-129F8	20.42	5.33	2.66	0.00	0.44
mature adipocyte, donor2	12232-129F9	23.66	9.96	3.53	1.66	0.00
mature adipocyte, donor3	12233-129G1	26.08	8.06	2.61	3.79	0.24
mature adipocyte, donor4	12234-129G2	34.22	7.37	1.05	3.69	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	19.54	4.53	1.67	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	0.00	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	10.11	4.05	0.74	1.47	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	8.58	7.31	0.32	3.49	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	5.97	5.97	2.13	1.71	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.10	5.06	0.34	1.86	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	11.25	5.09	1.06	0.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	3.85	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	4.31	6.82	0.36	2.15	0.36
medulla oblongata - adult, donor10196	10174-103C3	13.63	1.95	0.65	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	13.62	4.95	0.46	0.77	0.15
medulla oblongata, adult, pool1	10038-101F2	11.43	5.55	0.57	1.31	0.00
medulla oblongata, newborn, donor10223	10361-105F1	12.85	5.55	1.04	2.78	0.00
medulloblastoma cell line:D283 Med	10838-111E1	49.15	11.51	1.33	0.22	0.66
medulloblastoma cell line:ONS-76	10759-110E3	10.76	4.89	0.61	0.86	0.00
melanoma cell line:COLO 679	10514-107E1	18.69	6.18	1.44	0.86	0.29
melanoma cell line:G-361	10465-106H6	22.26	16.02	2.17	1.36	2.17
meningioma cell line:HKBMM	10691-109F7	22.25	4.70	1.09	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	42.30	12.34	1.76	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	37.85	8.81	2.85	1.30	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.03	11.81	0.77	2.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.72	8.18	1.27	0.73	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.53	6.21	2.90	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	22.62	6.88	0.98	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.33	9.44	1.16	1.35	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	11.80	0.69	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	37.07	8.75	2.06	1.72	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.49	9.32	0.58	1.04	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	18.70	6.10	1.99	1.06	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.45	7.56	1.08	1.08	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.07	5.83	1.42	0.85	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.34	5.93	1.32	0.99	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.87	5.53	0.97	0.69	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.27	3.49	2.44	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.88	4.49	0.82	1.63	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.42	5.03	0.72	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.83	2.69	0.93	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.66	3.65	0.68	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	15.52	5.03	0.42	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.19	5.53	0.75	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.91	4.73	1.66	0.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.62	6.26	0.74	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.30	4.86	0.57	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	25.26	6.74	1.68	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.09	4.11	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.65	3.84	0.51	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.32	3.93	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.79	4.01	1.54	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	14.83	4.00	1.18	1.65	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	18.95	3.72	1.35	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.50	3.14	1.57	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.27	2.78	2.32	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.04	5.48	2.31	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.85	5.13	2.23	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.63	5.29	0.96	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	5.13	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.80	7.05	2.01	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.19	2.87	1.64	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.61	5.15	2.15	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.21	9.42	1.62	1.62	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	7.27	4.36	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	9.06	2.13	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	24.53	11.45	4.09	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.44	10.11	2.72	1.55	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	6.30	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	10.93	4.97	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	20.16	8.89	1.78	2.96	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	15.84	2.44	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	29.14	12.03	1.90	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	41.39	19.66	3.10	4.14	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	30.09	4.30	8.60	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	35.93	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	6.89	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	51.75	25.26	2.85	3.26	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	66.73	25.42	1.59	2.38	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	47.16	24.76	4.13	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	52.68	25.25	4.99	4.05	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	64.16	22.72	4.01	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	15.37	2.37	4.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	23.11	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	38.55	24.78	4.13	6.20	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	35.13	13.36	4.45	3.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	21.31	10.09	2.24	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	37.53	16.54	8.27	2.54	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	38.69	14.91	2.82	3.63	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	8.72	6.54	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	46.88	13.94	11.40	5.07	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	38.84	12.14	2.43	4.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	13.56	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.89	12.36	6.59	1.65	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	27.98	11.91	2.78	2.38	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	33.42	6.17	3.57	2.27	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	16.30	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	6.19	1.55	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	22.68	9.45	1.89	1.18	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	23.86	10.66	1.39	3.01	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	15.10	8.43	0.82	0.62	0.31
mesothelioma cell line:Mero-25	10850-111F4	23.83	11.35	0.91	4.31	0.00
mesothelioma cell line:Mero-41	10851-111F5	21.51	5.87	2.20	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	15.72	3.10	0.22	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	22.34	9.20	0.53	2.10	0.00
mesothelioma cell line:Mero-83	10854-111F8	23.49	5.28	1.19	0.85	0.00
mesothelioma cell line:Mero-84	10855-111F9	19.21	3.29	1.01	1.52	0.00
mesothelioma cell line:Mero-95	10856-111G1	23.40	5.38	1.86	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	13.91	2.98	0.99	0.66	0.50
mesothelioma cell line:NCI-H226	10846-111E9	17.38	7.06	0.36	1.99	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	12.98	3.42	0.68	0.85	0.17
mesothelioma cell line:NCI-H28	10845-111E8	30.03	6.87	2.80	1.27	0.00
mesothelioma cell line:No36	10857-111G2	26.10	6.85	2.61	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	14.90	7.59	0.54	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	10.17	0.77	0.38	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	20.03	3.42	1.47	0.49	0.24
migratory langerhans cells, donor3	11903-125F4	28.18	5.20	1.79	0.18	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	11.10	9.14	1.63	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	17.38	12.72	0.85	1.06	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.52	0.92	0.69	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.70	5.14	1.90	0.95	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	58.39	11.64	2.59	0.92	0.55
myeloma cell line:PCM6	10474-106I6	26.09	2.37	1.58	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.74	4.06	1.52	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.04	5.10	0.39	1.18	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	20.95	4.23	1.56	0.22	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.94	5.74	2.35	0.44	0.15
nasal epithelial cells, donor2	12227-129F4	19.87	7.73	1.10	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	73.16	7.59	0.69	1.84	0.23
neuroblastoma cell line:NB-1	10539-107G8	41.91	22.45	1.87	3.55	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	42.60	14.76	1.27	0.63	0.42
neuroblastoma cell line:NH-12	10555-107I6	85.72	7.83	0.93	1.30	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	33.69	4.51	0.71	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	28.51	7.60	1.43	0.79	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	55.95	11.27	1.41	1.81	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	14.62	5.09	1.91	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	17.57	3.73	0.53	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	22.15	2.88	0.00	0.85	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	27.22	7.20	2.40	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.80	10.58	1.60	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.61	5.26	0.26	1.58	0.79
nucleus accumbens, adult, pool1	10037-101F1	9.09	7.41	0.56	1.59	0.00
occipital cortex - adult, donor10196	10172-103C1	4.12	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	15.03	6.17	0.27	1.61	0.00
occipital cortex, newborn, donor10223	10355-105E4	9.83	6.19	0.73	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	9.71	6.82	1.05	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	23.60	5.15	1.29	0.43	1.72
occipital pole, adult, pool1	10036-101E9	10.56	7.41	0.79	1.58	0.00
olfactory region, adult	10195-103E6	9.17	6.69	0.96	0.96	0.00
optic nerve, donor1	10277-104E7	20.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	22.55	7.06	1.94	2.28	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	19.10	5.36	0.55	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.94	1.52	0.51	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	27.72	11.67	0.92	1.50	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	13.23	6.17	0.29	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	5.61	1.87	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	20.36	10.39	0.42	1.91	0.21
ovary, adult, pool1	10020-101D2	20.88	4.89	1.05	1.05	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	9.53	2.75	0.37	0.37	0.00
pancreas, adult, donor1	10049-101G4	50.79	8.47	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.97	3.91	1.68	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	18.23	6.81	1.19	1.02	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	12.92	2.81	0.83	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	9.06	8.24	0.82	2.47	0.00
parietal cortex, adult, donor10258	10373-105G4	11.01	2.20	0.73	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	7.52	7.52	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	9.41	7.13	0.57	2.28	0.00
parietal lobe, adult, pool1	10034-101E7	10.22	10.05	0.79	1.50	0.00
parietal lobe, fetal, donor1	10072-101I9	8.73	2.91	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.61	6.73	1.87	2.24	0.37
parotid gland, adult	10199-103F1	22.82	2.47	0.62	0.62	0.00
penis, adult	10200-103F2	15.58	3.22	0.00	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	11.90	0.93	0.00	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.44	2.48	0.44	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	7.74	9.68	0.65	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	16.58	7.11	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	10.03	4.39	0.00	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	19.22	10.12	1.01	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	25.54	5.73	2.08	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	20.43	5.11	2.55	3.40	0.85
placenta, adult, pool1	10021-101D3	22.36	4.62	1.40	0.54	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	29.13	5.96	0.66	1.72	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	33.93	5.91	2.02	0.62	0.16
pons, adult, pool1	10033-101E6	10.84	7.92	1.46	1.98	0.00
postcentral gyrus, adult, pool1	10032-101E5	9.41	9.41	1.13	1.22	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	4.18	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.33	4.08	2.48	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	35.76	15.25	1.27	2.36	0.18
prostate, adult, pool1	10022-101D4	21.77	4.26	1.18	1.09	0.00
putamen, adult, donor10196	10176-103C5	7.08	8.03	1.65	1.65	0.00
putamen, adult, donor10252	10152-102I8	19.61	5.88	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	8.74	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.97	8.94	0.97	2.90	0.24
putamen, newborn, donor10223	10365-105F5	7.50	10.50	0.75	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	11.64	3.20	0.58	0.87	0.00
rectum, fetal, donor1	10067-101I4	31.99	5.56	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.90	2.97	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.53	0.41	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	20.87	5.57	1.69	0.99	0.10
retinoblastoma cell line:Y79	10475-106I7	40.27	7.27	2.60	2.08	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.20	5.16	0.61	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	30.93	8.72	1.41	1.97	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	6.06	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	31.40	8.42	2.91	1.46	0.49
salivary acinar cells, donor2	11772-123I8	35.25	12.80	2.48	2.34	1.10
salivary acinar cells, donor3	11773-123I9	29.13	11.92	0.66	2.65	0.00
salivary gland, adult, pool1	10093-102C3	36.60	2.86	3.43	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	13.24	3.88	1.01	0.51	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.28	2.82	0.94	0.47	0.59
seminal vesicle, adult	10201-103F3	13.23	2.12	1.06	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.28	8.99	1.70	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	26.67	6.54	1.01	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	20.07	4.01	3.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.25	6.04	2.15	1.07	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	18.68	3.65	1.55	0.99	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	51.61	9.29	2.19	1.81	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	2.13	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	29.14	4.08	1.56	1.20	0.12
skeletal muscle, fetal, donor1	10066-101I3	22.11	2.01	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	18.94	6.94	3.79	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	29.68	7.34	2.67	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	29.63	14.50	0.32	0.95	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.35	14.84	3.28	1.54	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	35.77	5.60	1.48	0.66	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	38.44	4.50	0.97	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	28.55	5.67	2.18	0.87	0.00
small intestine, adult, pool1	10024-101D6	40.37	11.59	4.78	1.79	0.48
small intestine, fetal, donor1	10064-101I1	28.01	5.16	1.72	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.36	4.10	1.54	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	13.96	1.81	0.52	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	24.93	2.41	1.07	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	8.95	2.98	1.15	1.38	0.00
spinal cord, adult, donor10252	10159-103A6	13.01	3.15	0.79	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	11.07	3.46	1.38	4.84	0.00
spinal cord, fetal, donor1	10056-101H2	14.64	9.15	0.61	3.66	0.00
spinal cord, newborn, donor10223	10359-105E8	22.50	4.13	0.00	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.45	2.99	0.30	0.45	0.00
spleen, adult, pool1	10025-101D7	15.75	2.97	0.55	0.44	0.00
spleen, fetal, pool1	10044-101F8	19.63	3.58	0.40	0.64	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.94	2.38	0.93	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	17.47	5.13	1.14	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	23.41	11.88	2.80	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.07	4.69	0.00	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	18.91	8.22	2.03	1.24	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.56	5.08	0.85	2.54	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	62.19	9.73	6.35	1.69	0.00
stomach, fetal, donor1	10062-101H8	24.56	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	20.51	3.42	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	14.54	2.49	1.25	1.25	0.21
substantia nigra, adult, donor10258	10371-105G2	16.03	5.17	1.55	4.66	0.52
substantia nigra, newborn, donor10223	10358-105E7	10.60	4.95	0.71	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	29.12	6.42	1.38	2.98	1.15
temporal lobe, adult, pool1	10031-101E4	11.53	9.24	1.44	2.71	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	21.37	6.41	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	22.42	6.59	0.88	0.88	0.44
tenocyte, donor1	11763-123H8	20.95	5.24	1.75	1.05	0.00
tenocyte, donor2	11765-123I1	43.49	6.10	1.91	0.38	0.38
tenocyte, donor3	11768-123I4	22.61	6.30	2.22	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	30.76	15.13	0.85	2.21	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	30.52	6.94	0.46	0.31	0.31
teratocarcinoma cell line:PA-1	10807-111A6	21.08	8.37	1.08	1.08	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	33.39	17.52	1.02	3.30	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.13	6.43	0.00	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	17.78	3.71	0.55	0.98	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	25.40	2.93	1.95	0.98	0.98
testis, adult, pool1	10026-101D8	21.69	9.13	1.61	1.18	0.86
testis, adult, pool2	10096-102C6	15.79	5.41	4.96	4.96	0.00
thalamus - adult, donor10196	10168-103B6	3.31	4.42	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	13.60	4.53	1.09	1.41	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	3.08	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	13.18	6.59	0.99	2.47	0.16
thalamus, newborn, donor10223	10366-105F6	4.03	8.63	0.58	2.88	0.00
throat, adult	10209-103G2	20.72	1.75	1.25	0.25	0.25
throat, fetal, donor1	10061-101H7	18.89	3.35	1.83	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	19.48	6.56	1.19	0.79	0.00
thymus, adult, pool1	10027-101D9	35.59	3.58	1.39	0.60	0.89
thymus, fetal, pool1	10043-101F7	28.89	3.74	0.83	0.52	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.83	3.19	1.20	0.66	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	29.20	7.12	0.42	0.98	0.00
thyroid, adult, pool1	10028-101E1	40.40	5.88	2.33	0.75	0.37
thyroid, fetal, donor1	10060-101H6	18.19	2.11	1.58	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	3.08	3.08	3.08	0.00
tongue, adult	10203-103F5	15.58	2.56	0.93	0.23	0.93
tongue, fetal, donor1	10059-101H5	19.70	2.76	0.79	0.39	0.00
tonsil, adult, pool1	10047-101G2	23.14	4.11	1.80	0.20	0.20
trachea, adult, pool1	10029-101E2	21.02	4.74	1.55	0.33	0.16
trachea, fetal, donor1	10058-101H4	18.47	8.46	0.77	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.40	5.67	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	56.94	17.22	2.13	1.62	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	49.20	15.51	1.25	3.92	1.41
tridermal teratoma cell line:HGRT	10694-109G1	22.83	3.81	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.68	1.61	0.51	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	18.78	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	28.84	3.58	1.71	0.51	0.17
uterus, fetal, donor1	10055-101H1	21.50	2.05	1.02	0.00	0.00
vagina, adult	10204-103F6	24.56	3.88	1.29	0.65	0.65
vein, adult	10191-103E2	20.60	3.51	0.88	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	39.25	3.74	1.34	0.53	0.53